Could a simple home workout boost postpartum recovery?

NCT ID NCT07790289

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Sep 04, 2026 · Updated 5 times

Summary

This pilot trial tests whether a 12-week home-based exercise program, called ASK, is feasible and beneficial for postpartum women who had high blood pressure during pregnancy. The program combines aerobic exercise, strength training, and Kegel exercises, guided by a mobile app and wearable device. Researchers will compare women who follow the program with those receiving standard postnatal care, measuring outcomes like recovery, sleep quality, and quality of life. The goal is to see if this approach can improve postpartum health and well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A 12-week home-based exercise program combining aerobic, strength, and Kegel exercises, delivered via an app and wearable device.
What this could lead to
If it works, this could point toward a practical, home-based exercise program that helps new mothers recover faster and feel better after childbirth.
What could go wrong
This is a small pilot study with only 40 participants, so results may not apply to all postpartum women. The program requires regular exercise, and some women may find it hard to stick with.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2026

An estimate. Start dates often move.

Expected to finish

Nov 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female Asian postpartum women aged 18 to 45 years * Singleton pregnancy * 6 to 8 weeks postpartum at the time of enrolment * Medically stable after childbirth * Physically able to participate in low-to-moderate intensity exercise training * Able and willing to participate in the 12-week study programme * Able to use the study app and wearable device, or willing to receive instruction on their use * Able to provide written informed consent Exclusion Criteria: * Multiple pregnancy * Severe postpartum medical complications or conditions contraindicating exercise participation * Severe cardiovascular, respiratory, neurological, or major musculoskeletal conditions that may limit safe participation in exercise * Current use of medication likely to substantially affect cardiac function, including heart failure therapy * Antibiotic treatment within the preceding month * Severe mental illness or other condition affecting the ability to provide informed consent or comply with study procedures * Any medical, obstetric, or psychological condition judged by the research team or attending clinician to make participation unsafe or inappropriate * Inability or unwillingness to adhere to the 12-week ASK programme or study assessments

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Body composition are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Department of Obstetrics and Gynaecology, The Chinese University Of Hong Kong

    Hong Kong, Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.